Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michelle Bongiorno
PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Related publications
131 Loss of PD-L1 Expression in Metastatic Merkel Cell Carcinoma Strongly Correlates With a Poor Prognosis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
JAMA Oncology
Cancer Research
Oncology
Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Mo2 - Modelling Overall Survival in Immunotherapy Using Parametric Techniques: Avelumab in Previously Treated Metastatic Merkel Cell Carcinoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Radiotherapy for Metastatic Merkel Cell Carcinoma: A Review of the Literature
Journal of Skin Cancer
Dermatology
Oncology
Diffuse Lichen Planus-Like Keratoses and Clinical Pseudo-Progression Associated With Avelumab Treatment for Merkel Cell Carcinoma, a Case Report
BMC Cancer
Cancer Research
Oncology
Genetics
Avelumab, an Anti-Pd-L1 Antibody, in Patients With Locally Advanced or Metastatic Breast Cancer: A Phase 1b JAVELIN Solid Tumor Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
Avelumab in the Treatment of Patients With Merkel Cell Carcinoma: Initial Results of Early Access Program in Russia
Malignant tumours
